Reporting of adverse drug events in the Veterans Health Administration for patients whose treatment with empagliflozin or apixaban was discontinued.

CONCLUSION: We found substantial underreporting of apixaban and empagliflozin ADEs that became worse at each higher level of spontaneous reporting.
PMID: 31756249 [PubMed - as supplied by publisher]

Source: American Journal of Health-System Pharmacy : AJHP - November 21, 2019 Category: Drugs & Pharmacology Authors: Fina PM, Cunningham FE, Zhao X, Glassman PA, Moore VR, Au A, Aspinall SL Tags: Am J Health Syst Pharm Source Type: research